Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors

Clinical trial NCT07224568 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07224568
Sponsor: Seattle Children's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor (Excluding CNS)Hepatocellular Carcinoma Liver Cell Carcinoma Liposarcoma Yolk Sac Tumor Rhabdomyosarcoma

Start date: 2026-04-01
Primary completion: 2030-08-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.